Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Wells Fargo CEO: Q4 Severance Costs May Be Near $1 Billion
Wells Fargo said it could face nearly $1 billion in severance costs in the fourth quarter.
Supreme Court Throws Out Case That Could Have Limited Lawsuits Over Disability Access
The Supreme Court on Tuesday dismissed a case surrounding a Maine hotel that could have made it harder for people with disabilities to learn in advance whether a hotel's accommodations meet their needs.
'GTA VI' Trailer Releases Early After Leak
The highly-anticipated trailer for Grand Theft Auto VI is out earlier than expected.
AT&T Selects Ericsson to Build New Network
AT&T announced a new partnership with Swedish communications company Ericsson.
23andMe Data Hack Affects 6.9 Million Users
Hackers accessed the personal data of 6.9 million users via the genetic testing company 23andMe.
Stocks Fall After Losing Session on Monday
Stocks fell after the opening bell on Tuesday morning as signs pointed to another losing session.
Bitcoin Has Surpassed $41,000 for the First Time Since April 2022. What's Behind the Price Surge?
Bitcoin is once again having a moment. On Monday, the world's largest cryptocurrency soared past $41,000 for the first time in over a year and a half — and marking a 150% rise so far this year.
Christmas Tree Prices Rising
Tree farmers are raising prices for Christmas trees.
Small Businesses Hiring at Higher Rate
Analysis shows smaller businesses are hiring more people.
